Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin/Pegasys for Recurrent Hepatitis C After Liver Transplant
NCT00466219Phase 3Completed
- Start
- May 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of ribavirin, peginterferon alfa-2a in hepatitis C (HCV). Started May 2002; status: completed.
02
Drugs
ribavirinpeginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00466219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466219.